Team Archive - Page 12 of 19 - NFCR

Kanaga Sabapathy, Ph.D.

Head, Division of Cellular and Molecular Research, National Cancer Center Singapore Dr. Sabapathy obtained his Ph.D. in Molecular and Cellular Immunology from the Institute of Molecular and Cell Biology (IMCB), A*STAR, Singapore, in 1995. After a post-doctoral stint at the Institute of Molecular Pathology in Vienna, Austria, he moved to…...

Read more

Ruggero De Maria, M.D.

President, Alliance Against Cancer; Director, Institute of Pathology, Catholic University, Rome, Italy  Professor Ruggero De Maria obtained his M.D. at the University of Catania (1989) and completed his residence training in endocrinology at the University of Palermo (1994). During his postdoc at the Department of Experimental Medicine, University of Rome,…...

Read more

Webster Cavenee, Ph.D.

Director of Strategic Alliances, Ludwig Institute for Cancer Research Distinguished Professor of Medicine, University of California San Diego Dr. Cavenee did his graduate and postdoctoral training in cell biology, biochemistry and human genetics. He received his Ph.D. with honors in 1977 from the University of Kansas Medical School and then…...

Read more

Alfred Slanetz, Ph.D.

Chairman of the Board Dr. Alfred Slanetz is the founder, president, and chief executive officer of Geneius and has been since its incorporation. He also has served as a director on Geneius’s board since its incorporation in 2012. Geneius, an immuno-oncology start-up, is researching ways to help cancer patients’ immune…...

Read more

Hali Hartmann, Ph.D.

Making Cures Possible Since 2008...

Read more

Jane Sui

Making Cures Possible Since 2014...

Read more

Camille Finley

Making Cures Possible Since 2025...

Read more

Shirly Shen

Making Cures Possible Since 2025...

Read more